Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2013
10/03/2013WO2013144655A1 Method and apparatus
10/03/2013WO2013144632A1 Treatment of proliferative diseases with pyrimidodiazepinones
10/03/2013WO2013144554A1 Production of near monodisperse particles using milling and membrane separation.
10/03/2013WO2013144374A1 Biorelevant compositions
10/03/2013WO2013144369A1 Material, method for preparing same, and uses thereof
10/03/2013WO2013144341A1 Microsphere compositions, preparation method and applications thereof
10/03/2013WO2013144206A1 Nonwoven membrane as a drug delivery system
10/03/2013WO2013144176A1 Controlled release formulatin comprising mesalamine
10/03/2013WO2013143891A1 Nicotine formulation
10/03/2013WO2013143688A1 Taste-masked ibuprofen granules
10/03/2013WO2013143683A1 Rna formulation for immunotherapy
10/03/2013WO2013143555A1 Rna formulation for immunotherapy
10/03/2013WO2013143323A1 Application of gastrodin as solubilizer and method for preparing injection or powder for injection
10/03/2013WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection
10/03/2013WO2013143300A1 Sustained-release preparation of fulvestrant or derivatives thereof and preparation method therefor
10/03/2013WO2013143299A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013143298A1 Fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013142996A1 Magnesium phosphate gels
10/03/2013WO2013142912A1 Methods and compositions for reducing ocular discomfort
10/03/2013WO2013123139A8 Methods, compositions, and devices for supplying dietary fatty acid needs
10/03/2013WO2013098842A3 Novel film coating composition
10/03/2013WO2012156527A9 Pharmaceutical composition having improved bioavailability
10/03/2013US20130261593 Device, System, and Method for Delivery of Sugar Glass Stabilized Compositions
10/03/2013US20130261572 Patch
10/03/2013US20130261526 Hydrogel compositions
10/03/2013US20130261188 Ibuprofen Solid Oral Dosage Composition Comprising a Methacrylic Acid Copolymer
10/03/2013US20130261184 Controlled release pharmaceutical compositions of pregabalin
10/03/2013US20130261179 Stabilised Prostaglandin Composition
10/03/2013US20130261152 Orally effective methylphenidate extended release powder and aqueous suspension product
10/03/2013US20130261145 Pharmaceutical formulation containing gelling agent
10/03/2013US20130261144 Pharmaceutical Formulation Containing Gelling Agent
10/03/2013US20130261143 Pharmaceutical Formulation Containing Gelling Agent
10/03/2013US20130261097 Pharmaceutical composition and method for treating hypogonadism
10/03/2013US20130261096 Formulation For Hormonotherapy
10/03/2013US20130261095 Dexamethasone Formulations in a Biodegradable Material
10/03/2013US20130261091 Salicylic Acid Gel
10/03/2013US20130260608 Coaxial connector having detachable locking sleeve
10/03/2013US20130260015 Tamper resistant dosage forms
10/03/2013US20130259947 Oral metronidazole pharmaceutical compositions
10/03/2013US20130259945 Anti-malaria compositions and methods
10/03/2013US20130259944 Methods and compositions for treating cancer with platinum particles
10/03/2013US20130259943 Aerosol composition with enhanced dispersion effects
10/03/2013US20130259942 Particulate substances comprising ceramic particles for delivery of biomolecules
10/03/2013US20130259941 Controlled release dosage forms
10/03/2013US20130259940 Tamper resistant dosage forms
10/03/2013US20130259939 Tamper resistant dosage forms
10/03/2013US20130259938 Tamper resistant dosage forms
10/03/2013US20130259937 Amphipathic lipid-based sustained release compositions
10/03/2013US20130259934 Implantable tizanidine compositions and methods of treatment thereof
10/03/2013US20130259933 Capsule which disintegrates specifically in the large intestine
10/03/2013US20130259932 Controlled release formulations of levodopa and uses thereof
10/03/2013US20130259931 Oral pharmaceutical compositions of nebivolol and process for their preparation
10/03/2013US20130259928 Generation of virosome particles
10/03/2013US20130259922 Liposomal formulations of lipophilic compounds
10/03/2013US20130259921 Treatment Of Diabetic Patients With A Stent And An Adjunctive Drug Formulation
10/03/2013US20130259920 Process for the preparation of a hot-melt extruded laminate
10/03/2013US20130259918 Adhesive label with bittering agent and fluidifying agents for natural airway secretions
10/03/2013US20130259911 Biobeneficial coating compositions and methods of making and using thereof
10/03/2013US20130259907 Biodegradable Drug Delivery Composition
10/03/2013US20130259905 Composition capable of inducing endoplasmic reticulum stress
10/03/2013US20130259904 Prasugrel containing quickly released stable oral pharmaceutical compositions
10/03/2013US20130259903 Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
10/03/2013US20130259852 Lysozyme gel formulations
10/03/2013US20130256932 Method for preparing a hemisphere-shaped dosage form containing drug and applications thereof
10/02/2013EP2645099A1 Biorelevant compositions
10/02/2013EP2644622A1 Micronized starch and methods for manufacturing same
10/02/2013EP2644594A1 Cancer Cell Targeting Using Nanoparticles
10/02/2013EP2644213A1 Drug-containing bioabsorbable fibers and implants
10/02/2013EP2644197A1 Novel Pharmaceutical Compositions of Entecavir
10/02/2013EP2644196A1 Pharmaceutical compositions of Entecavir
10/02/2013EP2644193A1 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
10/02/2013EP2644192A1 Cancer Cell Targeting Using Nanoparticles
10/02/2013EP2644191A1 Nonwoven membrane as a drug delivery system
10/02/2013EP2644190A1 Formulation for hormone therapy
10/02/2013EP2644189A1 Stable bortezomib formulations
10/02/2013EP2643396A1 Method for coating particles with calcium phosphate and particles, microparticles and nanoparticles formed thereof
10/02/2013EP2643372A2 Stealth polymeric particles for delivery of bioactive or diagnostic agents
10/02/2013EP2643320A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/02/2013EP2643057A1 An implant for the controlled release of pharmaceutically active agents
10/02/2013EP2643045A2 Therapeutic methods and compositions for solid delivery
10/02/2013EP2643022A1 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
10/02/2013EP2643021A1 Binding drugs with nanocrystalline cellulose (ncc)
10/02/2013EP2643003A1 Vaginal composition based on alkyl polyglucosides
10/02/2013EP2642996A2 Pharmaceutical compositions
10/02/2013EP2642993A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
10/02/2013EP2642985A1 Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form
10/02/2013EP2642984A1 Method for encapsulating particles
10/02/2013EP2642983A2 Ingestible device with pharmaceutical product
10/02/2013EP2642982A2 Stable cannabinoid compositions and methods for making and storing them
10/02/2013EP2642981A1 Solid dosage forms of oleyl phosphocholine
10/02/2013EP2642980A2 Pediatric formulation
10/02/2013EP2642979A1 A pharmaceutical composition
10/02/2013EP2642978A2 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders
10/02/2013EP2642872A1 Protective hydrocolloid for active ingredients
10/02/2013CN203220605U Quick-acting tumor pain relieving bag
10/02/2013CN203220604U Valnemulin long-acting granular pill
10/02/2013CN203220603U Composite capsule
10/02/2013CN103338789A Pharmaceutical composition containing drug having poor water solubility
10/02/2013CN103338788A Patch preparation
10/02/2013CN103338781A Compositions and methods of aloe polysaccharides
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 2991